Unitree Robotics' Shanghai stock market debut

Unitree priced its Shanghai STAR Market IPO at 150.80 yuan a share, raising about 6.1 billion yuan (US$904 million) in China's first mainland listing of a humanoid robot maker ^[1]. When trading opened, shares gapped straight to 1,100 yuan, up 629% from the offer price and briefly valuing the company near 445 billion yuan, or roughly US$66 billion, before the rally cooled through the session and the stock closed up 460% at 845 yuan ^[1]. The scale of the pop traces back to the order book: the retail tranche of the offering was oversubscribed more than 8,000 times, a level of demand that all but guaranteed the opening trade would blow far past the IPO price before any price discovery could happen ^[1]. CGTN reported that the institutional side of the book was just as telling, with allocations to AI lab DeepSeek and Tencent alongside state-owned China National Petroleum Corporation, China Southern Power Grid and China Telecom - a mix of private AI money and state capital lining up next to the retail crowd. That dynamic also helps explain the intraday pullback - a market that opens on pure scarcity-driven euphoria typically gives some of it back once actual sellers show up, which is consistent with the gap between the 629% open and the 460% close.

What separates Unitree from most of the crowded humanoid robotics field is that it already makes money: 2025 revenue came in around 1.7 billion yuan (roughly $250 million) with adjusted profit near 591 to 600 million yuan ^[4]. As Humanoid Analytics founder Rinat Mirzaitov put it, that combination makes Unitree one of the few companies in the category with genuine revenue, profitability and production volume, in a sector still dominated by pre-revenue players ^[8]. But the post-IPO valuation appears to be pricing in far more than that track record justifies. Omdia chief analyst Lianne Jia Su, speaking to CGTN Europe, put it plainly: the valuation implies investors are 'betting on growth over near-term earnings,' and she cautioned against judging Unitree solely on one robot form factor. The numbers back up her caution: Q1 2026 results showed revenue up 68% year over year, yet adjusted net profit fell 52% as R&D and sales costs climbed, prompting the observation that the valuation is running ahead of the business ^[5]. HSBC analysts have gone further, warning that the industry-wide surge in reported robot shipment numbers - the kind of figures used to justify these valuations - could be illusionary rather than a signal of durable demand ^[4]. The tension is that Unitree is simultaneously the best-positioned company in its category and a stock now trading on assumptions about a market that does not yet exist at scale.

Unitree's debut was not scheduled in isolation - it landed on the same day the 2026 World Robot Conference opened in Beijing ^[2]. Separately, at an online investor meeting tied to the IPO, Wang Xingxing outlined plans to keep advancing embodied AI foundation models, scenario-based data collection, reinforcement learning, in-house core components and high-performance actuators across humanoid, quadruped and mecha robot forms ^[6]. He described the embodied AI industry as still at an early stage, comparable to the early days of home appliances and personal computers - a framing that positions Unitree's IPO less as a single company event and more as a marker of China's broader 'physical AI' industrial push ^[6]. DW News reported that China produced roughly 90% of the humanoid robots sold globally last year, a scale advantage that helps explain why a single Chinese listing could move markets the way Unitree's did. That push now runs directly into U.S. policy: the Trump administration banned imports of new foreign-made humanoid and quadruped robots in July 2026 on national security grounds, a restriction that bears directly on Unitree since roughly 13 to 18% of its revenue has come from the U.S. market ^[7]. With overseas sales making up 40 to 45% of revenue ^[4], the standoff over U.S. market access is less a footnote than a structural risk to the growth story investors just paid a 629% premium for.

Beneath the valuation headlines sits an unresolved question about what these robots actually do commercially. Unitree's own prospectus flagged that its robotic hands are not yet precise or durable enough for sustained commercial use, and observers note that many humanoid robots, including Unitree's, remain mainly used for demonstrations, performances and research rather than reliable large-scale industrial or commercial deployment ^[3]. Morningstar's Kangyuxiao Li frames this as the real competitive test ahead: whether companies, Chinese or American, can achieve reliable performance and attractive returns on investment in large-scale industrial and commercial deployments, not just in showcase settings ^[9]. That skepticism looks different depending on where you look online. X.com's finance and markets accounts - Coin Bureau, Wall St Engine and CNBC's own account - treated the 600%-plus pop as straightforward validation of China's humanoid and physical-AI boom, dwelling on the raw percentage and dollar valuation with little pushback. Reddit told a much less uniform story: threads on r/wallstreetbets and r/StockMarket debated whether humanoid robots have proven real commercial utility or are still closer to spectacle - 'clown show' was one recurring label - and flagged a price-to-earnings multiple above 100x as hard to square with Unitree's modest reported profit. Elsewhere on the platform, r/stocks threads raised a more practical complaint: foreign retail investors can't easily buy in at all, since STAR Market listings require a mainland brokerage account and aren't immediately eligible for southbound trading. That gap between platforms is itself the story: the same 629% number reads as vindication on one feed and as a red flag on another. Even Ethan Qi's read of the IPO as an industry benchmark cuts both ways: if Unitree's valuation becomes the reference point for the next wave of humanoid IPOs, the gap between demonstration-stage capability and commercial reliability becomes everyone's problem, not just Unitree's ^[3].